Announcements Trials

Browse Landscape

Phase

Status

Completed 4 Active not recruiting 2 Withdrawn 1 Unknown 1 Terminated 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 21 Neoplasms 6 Neoplasm Metastasis 5 Ovarian Neoplasms 3 Endometrial Neoplasms 3 Triple Negative Breast Neoplasms 2 Multiple Myeloma 2 Lymphoma, Non-Hodgkin 2 Hereditary Sensory and Autonomic Neuropathies 2 Fallopian Tube Neoplasms 2 Colorectal Neoplasms 2 Carcinoma, Renal Cell 2 Carcinoma, Ovarian Epithelial 2 Breast Diseases 2 von Hippel-Lindau Disease 1 Uterine Cervical Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumors Refractory to Standard Therapy 1 Solid Tumor, Adult 1 Solid Tumor 1 Sarcoma 1 Recurrence 1 Rare Tumor 1 Pancreatic Neoplasms 1 Neoplasms by Site 1 Neoplasm, Residual 1 Melanoma 1 Medulloblastoma 1 Malignant Female Reproductive System Neoplasm 1 Lung Neoplasms 1

Interventions

Doxorubicin 15 pembrolizumab 12 Cyclophosphamide 9 Surgical Procedures, Operative 8 Gemcitabine 8 Blood Specimen Collection 8 Ifosfamide 7 Surveys and Questionnaires 6 Nivolumab 6 Trabectedin 5 Radiotherapy 5 Magnetic Resonance Spectroscopy 5 Drug Therapy 5 fludarabine 4 Temozolomide 4 Specimen Handling 4 Radiation Dose Hypofractionation 4 Biopsy 4 selinexor 3 pazopanib 3 liposomal doxorubicin 3 cabozantinib 3 atezolizumab 3 anlotinib 3 Radiation 3 Observation 3 Docetaxel 3 Dacarbazine 3 trastuzumab deruxtecan 2 toripalimab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Sarcoma × palbociclib × Clear all

NCT06113809 2026-05-22

Palbociclib and Pembrolizumab in Sarcoma

University of Iowa

Phase 1 Recruiting

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡